Earnings Feed
Start Free
Lineage Cell Therapeutics, Inc.·4

Jul 2, 5:14 PM ET

BRADSHER NEAL C 4

4 · Lineage Cell Therapeutics, Inc. · Filed Jul 2, 2020

Insider Transaction Report

Form 4
Period: 2020-07-01
Lineage Cell Therapeutics, Inc.LCTX
Bradsher Neal C
10% Owner
Transactions
  • Award

    OPTION TO PURCHASE COMMON SHARES

    2020-07-01+40,000→ 40,000 total
    Exercise: $0.83Exp: 2030-07-01→ COMMON SHARES (40,000 underlying)
Holdings

  • OPTION TO PURCHASE COMMON SHARES

    Exercise: $3.15Exp: 2022-06-30→ COMMON SHARES (24,720 underlying)
    24,720

  • OPTION TO PURCHASE COMMON SHARES

    Exercise: $2.72Exp: 2021-06-30→ COMMON SHARES (24,720 underlying)
    24,720

  • OPTION TO PURCHASE COMMON SHARES

    Exercise: $2.06Exp: 2023-06-30→ COMMON SHARES (49,440 underlying)
    49,440

  • OPTION TO PURCHASE COMMON SHARES

    Exercise: $1.03Exp: 2029-06-30→ COMMON SHARES (40,000 underlying)
    40,000
Footnotes (3)
  • [F1]These options will vest and become exercisable on July 1, 2021, provided, that Neal C. Bradsher remains a member of the issuer's board of directors on that date.
  • [F2]The options were granted to Neal C. Bradsher by the issuer on July 1, 2020 as director compensation.
  • [F3]These options are currently exercisable.

Documents

1 file
  • 4
    ownership.xmlPrimary